Home › Triple-Negative Breast Cancer › Louisiana › Shreveport
Triple-Negative Breast Cancer clinical trials in Shreveport, LA
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Shreveport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Louisiana State University Health Sciences Shreveport ( Site 0029), Shreveport
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Louisiana State University Health Sciences Shreveport ( Site 0053), Shreveport
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
RecruitingEarly phase 1
- LSU Health Sciences Center, Shreveport
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Shreveport
- Breast Cancer8 studies
- Endometrial Cancer7 studies
- Ovarian Cancer7 studies
- Obesity7 studies
- Non-Small Cell Lung Cancer6 studies
- Cancer (all types)5 studies
- COPD5 studies
- Heart Failure4 studies
- Overweight4 studies
- Multiple Myeloma4 studies
- Cardiovascular Disease4 studies
- Steatotic Liver Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.